DC targeted therapy breaks immune tolerance against neoantigens in refractory lung adenocarcinoma
Preprint in Research Square (April 2023)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Preprint in Research Square (April 2023)
Article in Genome Instability & Disease (March 2023)
Article in Frontiers in Cell and Developmental Biology (March 2023)